Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Altmueller, Janine Dr.med. (47) Beule, Dieter Dr. (2) Blankenstein, Thomas Prof. Dr. (33) Blüthgen, Nils (1) Borodina, Tatiana Dr. (1) Braeuning, Caroline (1) Daniel, Peter Prof. Dr. (1) Dechend, Ralf Priv. Doz. (1) Fischer, Cornelius Dr. (1) Geisberger, Sabrina Yasmin Dr. (1) Henssen, Anton Prof. Dr. med. (1) Herse, Florian PD Dr. (1) Hinze, Christian Dr. med. Dipl.-Math. (1) Höpken, Uta Elisabeth PD Dr. (1) Kammertöns, Thomas Dr. (8) Kocks, Christine Dr. (1) Na, Il-Kang Dr. (1) Obermayer-Wasserscheid, Benedikt Dr. (1) Pezzutto, Antonio Prof. Dr. (4) Quedenau, Claudia (1) Rajewsky, Nikolaus Prof. Dr. (1) Sai, Somesh (1) Schmitt, Clemens Prof. Dr. (1) Sunaga-Franze, Daniele Yumi Dr. (1) Uckert, Wolfgang Prof. Dr. (2) (-) Bunse, Mario Dr. (1) (-) Kopp, Joachim Dr. (1) (-) Willimsky, Gerald Dr. (11) Advanced Light Microscopy (1) Animal Phenotyping (1) Bioinformatics and Omics Data Science (2) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (1) Experimentelle Ultrahochfeld-MR (1) Genetik metabolischer und reproduktiver Störungen (4) Genom-Editierung & Krankheitsmodelle (1) Magnetic Resonance (1) Mikroumgebung als Regulator bei Autoimmunität und Krebs (2) (-) Molekulare Immunologie und Gentherapie (12) Myologie (1) Neuroimmunologie-Labor (1) Proteom Dynamik (2) RNA Biologie und Posttranscriptionale Regulation (11) Systembiologie von Gen-regulatorischen Elementen (1) Transgenics (1) Translational Bioinformatics (3) Translationale Tumorimmunologie (2) Tumorgenetik und zelluläre Stressantworten (1) Zelluläre Neurowissenschaften (2) 1997 (1) 1998 (1) (-) 2000 (3) (-) 2002 (1) 2005 (4) (-) 2007 (2) 2008 (2) 2010 (4) 2011 (1) (-) 2013 (5) 2015 (2) 2016 (1) 2017 (1) 2018 (5) 2019 (3) 2020 (2) (-) 2021 (1) 2022 (8) 2023 (8) 2024 (1) 12 Ergebnisse: Active Filter: Bunse, Mario Dr.Kopp, Joachim Dr.Willimsky, Gerald Dr.Molekulare Immunologie und Gentherapie 20002002200720132021 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel 07. März 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky 05. Februar 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein 01. März 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein 01. August 2013 / Oncotarget Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? G. Willimsky U. Protzer P. Knolle M. Heikenwalder 20. April 2021 / eLife In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo G. Willimsky C. Beier L. Immisch G. Papafotiou V. Scheuplein-Schlosser A. Goede H.G. Holzhütter T. Blankenstein P.M. Kloetzel 01. Februar 2000 / Canc Res Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors G. Willimsky T. Blankenstein 01. Mai 2000 / Bone Marrow Transplant Allogeneic vaccination for renal cell carcinoma: development and monitoring H. Pohla B. Frankenberger B. Stadlbauer R. Oberneder A. Hofstetter G. Willimsky A. Pezzutto B. Doerken T. Blankenstein D.J. Schendel 01. Dezember 2000 / Gene Ther Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse D.J. Schendel B. Frankenberger P. Jantzer S. Cayeux E. Noessner G. Willimsky B. Maget H. Pohla T. Blankenstein 01. Oktober 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
07. März 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky
05. Februar 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein
01. März 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein
01. August 2013 / Oncotarget Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? G. Willimsky U. Protzer P. Knolle M. Heikenwalder
20. April 2021 / eLife In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo G. Willimsky C. Beier L. Immisch G. Papafotiou V. Scheuplein-Schlosser A. Goede H.G. Holzhütter T. Blankenstein P.M. Kloetzel
01. Februar 2000 / Canc Res Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors G. Willimsky T. Blankenstein
01. Mai 2000 / Bone Marrow Transplant Allogeneic vaccination for renal cell carcinoma: development and monitoring H. Pohla B. Frankenberger B. Stadlbauer R. Oberneder A. Hofstetter G. Willimsky A. Pezzutto B. Doerken T. Blankenstein D.J. Schendel
01. Dezember 2000 / Gene Ther Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse D.J. Schendel B. Frankenberger P. Jantzer S. Cayeux E. Noessner G. Willimsky B. Maget H. Pohla T. Blankenstein
01. Oktober 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein